Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 2.08B | 2.07B | 2.06B | 1.77B | 1.61B | 1.74B |
Gross Profit | 799.04M | 804.53M | 787.90M | 637.89M | 599.75M | 597.61M |
EBITDA | 159.81M | 348.90M | 315.74M | 230.72M | 236.05M | 154.61M |
Net Income | 19.87M | 106.85M | 128.68M | 18.70M | 40.21M | -22.65M |
Balance Sheet | ||||||
Total Assets | 2.11B | 2.08B | 1.89B | 1.81B | 1.68B | 1.68B |
Cash, Cash Equivalents and Short-Term Investments | 451.64M | 369.12M | 549.61M | 632.59M | 640.17M | 480.21M |
Total Debt | 449.05M | 425.87M | 377.28M | 371.82M | 293.26M | 300.96M |
Total Liabilities | 764.38M | 721.55M | 627.95M | 629.62M | 504.56M | 496.06M |
Stockholders Equity | 1.31B | 1.32B | 1.23B | 1.14B | 1.17B | 1.16B |
Cash Flow | ||||||
Free Cash Flow | 193.37M | 142.63M | 61.97M | 99.47M | 229.96M | 106.67M |
Operating Cash Flow | 262.04M | 211.30M | 268.99M | 162.11M | 273.05M | 195.95M |
Investing Cash Flow | -17.13M | 1.42M | -300.36M | -11.89M | 30.44M | -79.31M |
Financing Cash Flow | -195.89M | -193.54M | -169.45M | -161.45M | -147.36M | -143.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | HK$387.60M | 8.18 | 9.10% | 3.95% | -4.97% | 111.21% | |
74 Outperform | HK$158.00M | 8.88 | 11.39% | 25.32% | -0.45% | 7.28% | |
66 Neutral | HK$585.61M | 29.49 | -1.12% | 12.75% | 1.30% | -85.43% | |
66 Neutral | HK$130.14M | 124.44 | 1.07% | ― | 3.44% | -43.75% | |
66 Neutral | £947.02M | 13.94 | 2.04% | 5.24% | 11.04% | 38.13% | |
64 Neutral | HK$988.32M | 98.11 | 0.84% | 4.62% | -8.35% | 96.66% | |
40 Underperform | HK$219.23M | ― | -22.75% | ― | -4.08% | -12.24% |